tradingkey.logo
tradingkey.logo
검색

Artivion Inc

AORT
관심 목록에 추가
23.970USD
+0.420+1.78%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.16B시가총액
93.41P/E TTM

자세한 내용은 Artivion Inc 회사

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc 정보

종목 코드 AORT
회사 이름Artivion Inc
상장일Feb 12, 1993
CEOMackin (James Patrick)
직원 수1600
유형Ordinary Share
회계 연도 종료Feb 12
주소1655 Roberts Boulevard N W
도시KENNESAW
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호30144
전화17704193355
웹사이트https://artivion.com/
종목 코드 AORT
상장일Feb 12, 1993
CEOMackin (James Patrick)

Artivion Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

자주 묻는 질문

Artivion Inc의 상위 5대 주주는 누구인가요?

Artivion Inc의 상위 5대 주주는 다음과 같습니다: Mr. John E. Davis

Artivion Inc(AORT)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Artivion Inc의 주식을 보유한 기관은 총 449곳이며, 이들이 보유한 주식의 총 가치는 약 45.29M로 전체 발행 주식의 93.40%를 차지합니다. 이는 2025Q4 대비 501666.00 증가한 수치입니다.

Artivion Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Artivion Inc의 Aortic stent grafts 부문이 가장 높은 매출을 기록했으며, 금액은 159.37M로 전체 매출의 36.11%를 차지했습니다.